ELF
e.l.f. Beauty, Inc. NYSE Listed Sep 22, 2016$64.20
+3.08%
vs $62.28
Mkt Cap $3.7B
52w Low $49.57
15.1% of range
52w High $146.67
50d MA $59.81
200d MA $86.45
P/E (TTM)
33.4x
EV/EBITDA
18.7x
P/B
4.7x
Debt/Equity
0.4x
ROE
4.3%
P/FCF
32.5x
RSI (14)
63.50
ATR (14)
$3.82
Beta
2.39
50d MA
$59.81
200d MA
$86.45
Avg Volume
4.4M
e.l.f. Beauty, Inc., together with its subsidiaries, provides cosmetic and skin care products under the e.l.f. Cosmetics, e.l.f. Skin, Well People, and Keys Soulcare brand names worldwide. The company offers eye, lip, face, face, paw, and skin care products. It sells its products through national and international retailers and direct-to-consumer channels, which include e-commerce platforms in the United States, and internationally primarily through distributors. The company was formerly known as J.A. Cosmetics Holdings, Inc. and changed its name to e.l.f. Beauty, Inc. in April 2016. e.l.f. Beauty, Inc. was founded in 2004 and is headquartered in Oakland, California.
570 10th Street · Oakland, CA 94607 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | AMC | 0.73 | 1.24 | +69.9% | 84.63 | +8.7% | -9.2% | +6.8% | -9.3% | -1.6% | +4.9% | — |
| Nov 5, 2025 | AMC | 0.57 | 0.68 | +19.9% | 117.83 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% | — |
| Aug 6, 2025 | AMC | 0.84 | 0.89 | +6.5% | 110.39 | -11.5% | -9.5% | +1.9% | +9.7% | +4.5% | +5.3% | — |
| May 28, 2025 | AMC | 0.72 | 0.78 | +8.2% | 90.50 | +20.3% | +23.6% | +0.6% | +1.1% | +0.9% | +2.1% | — |
| Feb 6, 2025 | AMC | 0.76 | 0.74 | -2.6% | 88.49 | -25.1% | -19.6% | +3.8% | +4.2% | -2.4% | -0.2% | — |
| Aug 8, 2024 | AMC | 0.84 | 1.10 | +31.0% | 187.95 | -11.0% | -14.4% | -10.7% | +3.5% | -2.2% | +7.0% | — |
| May 22, 2024 | AMC | 0.33 | 0.53 | +59.6% | 155.63 | +11.0% | +18.7% | +3.6% | +1.0% | -4.9% | -0.7% | — |
| Feb 6, 2024 | AMC | 0.57 | 0.74 | +29.6% | 173.32 | -1.2% | -4.9% | +4.1% | +1.7% | -1.5% | -2.4% | — |
| Nov 1, 2023 | AMC | 0.53 | 0.82 | +55.9% | 94.54 | +11.7% | +3.7% | -1.9% | +5.8% | +0.3% | -3.8% | — |
| Aug 1, 2023 | AMC | 0.56 | 1.10 | +96.4% | 116.50 | +15.5% | +14.3% | -0.8% | -3.0% | +2.1% | +0.5% | — |
| May 24, 2023 | AMC | 0.20 | 0.42 | +113.7% | 86.45 | +10.7% | +20.5% | -2.8% | +3.6% | -0.9% | +2.4% | — |
| Feb 1, 2023 | AMC | 0.23 | 0.48 | +106.2% | 58.51 | +18.4% | +15.0% | +3.6% | -1.5% | +4.9% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 | Bernstein | Initiates | Mkt Perform | $60 | $60.68 | $60.85 | +0.3% | +0.8% | +4.6% | +4.6% | -6.9% | +3.1% |
| May 1 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $63.97 | $63.10 | -1.4% | -5.4% | +2.2% | -3.9% | +3.4% | +0.6% |
| May 1 | Morgan Stanley | Downgrade | Overweight → Equal-Weight | $67 | $63.97 | $63.10 | -1.4% | -5.4% | +2.2% | -3.9% | +3.4% | +0.6% |
| Apr 28 | Baird | Maintains | Outperform → Outperform | — | $63.72 | $63.00 | -1.1% | -1.1% | -3.0% | +4.7% | -5.4% | +2.2% |
| Apr 17 | JP Morgan | Maintains | Overweight → Overweight | — | $69.25 | $70.94 | +2.4% | -3.5% | +2.4% | -2.1% | -2.1% | +1.0% |
| Apr 15 | Citigroup | Maintains | Buy → Buy | — | $68.90 | $69.15 | +0.4% | +1.4% | -0.9% | -3.5% | +2.4% | -2.1% |
| Apr 10 | BofA Securities | Maintains | Buy → Buy | — | $63.93 | $63.73 | -0.3% | +1.9% | +0.8% | +5.0% | +1.4% | -0.9% |
| Apr 7 | UBS | Maintains | Neutral → Neutral | — | $63.22 | $62.32 | -1.4% | -3.3% | +1.0% | +3.5% | +1.9% | +0.8% |
| Mar 30 | Deutsche Bank | Maintains | Hold → Hold | — | $61.05 | $61.31 | +0.4% | -2.8% | +2.1% | +2.8% | -1.8% | +3.4% |
| Feb 9 | TD Cowen | Maintains | Buy → Buy | — | $82.09 | $81.78 | -0.4% | -9.3% | -1.6% | +4.9% | -3.2% | +9.6% |
| Feb 5 | Citigroup | Maintains | Buy → Buy | — | $84.63 | $92.00 | +8.7% | -9.2% | +6.8% | -9.3% | -1.6% | +4.9% |
| Feb 5 | JP Morgan | Maintains | Overweight → Overweight | — | $84.63 | $92.00 | +8.7% | -9.2% | +6.8% | -9.3% | -1.6% | +4.9% |
| Feb 5 | UBS | Maintains | Neutral → Neutral | — | $84.63 | $92.00 | +8.7% | -9.2% | +6.8% | -9.3% | -1.6% | +4.9% |
| Jan 21 | TD Cowen | Maintains | Buy → Buy | — | $89.04 | $90.98 | +2.2% | +3.1% | +1.9% | +0.6% | -5.7% | -2.3% |
| Jan 14 | UBS | Maintains | Neutral → Neutral | — | $87.56 | $87.08 | -0.5% | -1.5% | +3.4% | +0.9% | -1.1% | +3.1% |
| Dec 22 | Piper Sandler | Maintains | Neutral → Neutral | — | $80.44 | $80.08 | -0.4% | -1.6% | -0.9% | +1.7% | +0.8% | -1.2% |
| Dec 18 | JP Morgan | Maintains | Overweight → Overweight | — | $78.85 | $79.85 | +1.3% | -2.0% | +4.1% | -1.6% | -0.9% | +1.7% |
| Nov 7 | Goldman Sachs | Maintains | Buy → Buy | — | $76.54 | $75.65 | -1.2% | -3.7% | +8.3% | -2.4% | -0.3% | -4.3% |
| Nov 6 | Baird | Maintains | Outperform → Outperform | — | $117.83 | $89.44 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% |
| Nov 6 | UBS | Maintains | Neutral → Neutral | — | $117.83 | $89.44 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% |
| Nov 6 | JP Morgan | Maintains | Overweight → Overweight | — | $117.83 | $89.44 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $117.83 | $89.44 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% |
| Nov 6 | Piper Sandler | Downgrade | Overweight → Neutral | — | $117.83 | $89.44 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% |
| Nov 6 | Jefferies | Maintains | Buy → Buy | — | $117.83 | $89.44 | -24.1% | -35.0% | -3.7% | +8.3% | -2.4% | -0.3% |
| Oct 28 | Jefferies | Maintains | Buy → Buy | — | $126.18 | $127.00 | +0.6% | +4.4% | -3.6% | -3.1% | -0.8% | -1.0% |
| Oct 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $127.42 | $128.40 | +0.8% | -0.2% | -2.7% | +1.1% | -1.8% | +2.7% |
| Oct 20 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $136.92 | $136.81 | -0.1% | -6.9% | -0.2% | -2.7% | +1.1% | -1.8% |
| Oct 10 | JP Morgan | Maintains | Overweight → Overweight | — | $144.97 | $146.51 | +1.1% | -10.5% | +2.3% | -0.2% | +1.2% | +1.3% |
| Oct 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $140.60 | $147.75 | +5.1% | +3.2% | -0.1% | -10.5% | +2.3% | -0.2% |
| Oct 8 | UBS | Maintains | Neutral → Neutral | — | $140.60 | $147.75 | +5.1% | +3.2% | -0.1% | -10.5% | +2.3% | -0.2% |
| Oct 2 | Goldman Sachs | Maintains | Buy → Buy | — | $135.20 | $135.77 | +0.4% | +0.5% | -1.0% | +2.8% | +1.6% | +3.2% |
| Sep 17 | BofA Securities | Maintains | Buy → Buy | — | $143.28 | $145.91 | +1.8% | +2.0% | +0.4% | -4.6% | -1.9% | -0.9% |
| Sep 10 | B. Riley Securities | Maintains | Buy → Buy | — | $138.83 | $139.10 | +0.2% | -3.2% | +2.7% | -2.1% | +6.8% | -0.8% |
| Sep 8 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $133.97 | $135.63 | +1.2% | +3.0% | +0.6% | -3.2% | +2.7% | -2.1% |
| Sep 2 | Deutsche Bank | Downgrade | Buy → Hold | — | $125.00 | $120.46 | -3.6% | +0.5% | +3.6% | +2.7% | +0.2% | +3.0% |
| Aug 11 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $101.77 | $107.37 | +5.5% | +9.7% | +4.5% | +5.3% | -2.7% | -2.7% |
| Aug 7 | UBS | Maintains | Neutral → Neutral | — | $110.39 | $97.68 | -11.5% | -9.5% | +1.9% | +9.7% | +4.5% | +5.3% |
| Aug 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $110.39 | $97.68 | -11.5% | -9.5% | +1.9% | +9.7% | +4.5% | +5.3% |
| Aug 7 | Goldman Sachs | Maintains | Buy → Buy | — | $110.39 | $97.68 | -11.5% | -9.5% | +1.9% | +9.7% | +4.5% | +5.3% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $110.39 | $97.68 | -11.5% | -9.5% | +1.9% | +9.7% | +4.5% | +5.3% |
| Aug 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $110.39 | $97.68 | -11.5% | -9.5% | +1.9% | +9.7% | +4.5% | +5.3% |
| Jul 25 | JP Morgan | Maintains | Overweight → Overweight | — | $119.22 | $119.89 | +0.6% | +1.4% | +0.1% | -0.8% | +2.8% | -1.7% |
| Jul 17 | UBS | Maintains | Neutral → Neutral | — | $108.51 | $108.20 | -0.3% | +2.2% | +6.1% | -5.1% | +4.0% | +1.4% |
| Jul 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $116.99 | $118.27 | +1.1% | +0.6% | -1.9% | -4.7% | -3.6% | +0.8% |
| Jun 20 | BofA Securities | Maintains | Buy → Buy | — | $122.24 | $122.32 | +0.1% | -2.0% | +2.7% | -1.0% | +2.9% | -0.4% |
| Jun 13 | B. Riley Securities | Maintains | Buy → Buy | — | $128.54 | $127.11 | -1.1% | -2.6% | +0.8% | -0.5% | -2.7% | -2.0% |
| Jun 6 | Truist | Maintains | Buy → Buy | — | $115.80 | $119.42 | +3.1% | +1.6% | -1.0% | +1.2% | +5.6% | +3.2% |
| Jun 6 | Baird | Maintains | Outperform → Outperform | — | $115.80 | $119.42 | +3.1% | +1.6% | -1.0% | +1.2% | +5.6% | +3.2% |
| Jun 2 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $112.49 | $112.97 | +0.4% | +1.1% | +0.9% | +2.1% | -1.2% | +1.6% |
| May 30 | Truist | Maintains | Buy → Buy | — | $111.84 | $112.16 | +0.3% | +0.6% | +1.1% | +0.9% | +2.1% | -1.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Milsten Scott | — | Sell | 4,162 | $51.53 | $214K | 144,581 | +0.77% | +3.08% |
| Jun 9, 2026 | MARCHISOTTO KORY | See Remarks | Sell | 4,352 | $51.53 | $224K | 181,868 | +0.77% | +3.08% |
| Jun 9, 2026 | FIELDS MANDY J | See Remarks | Sell | 4,327 | $51.53 | $223K | 106,961 | +0.77% | +3.08% |
| Jun 9, 2026 | Franks Joshua Allen | SVP, Operations | Sell | 3,505 | $51.53 | $181K | 150,027 | +0.77% | +3.08% |
| Jun 9, 2026 | Hartnett Jennifer Catherine | Chief Commercial Officer | Sell | 4,352 | $51.53 | $224K | 54,056 | +0.77% | +3.08% |
| Jun 4, 2026 | Milsten Scott | — | Sell | 8,512 | $51.94 | $442K | 148,743 | +5.47% | +0.77% |
| Jun 4, 2026 | MARCHISOTTO KORY | See Remarks | Sell | 8,512 | $51.94 | $442K | 186,220 | +5.47% | +0.77% |
| Jun 4, 2026 | FIELDS MANDY J | See Remarks | Sell | 8,464 | $51.94 | $440K | 111,288 | +5.47% | +0.77% |
| Jun 4, 2026 | Franks Joshua Allen | SVP, Operations | Sell | 6,854 | $51.94 | $356K | 153,532 | +5.47% | +0.77% |
| Jun 4, 2026 | Hartnett Jennifer Catherine | Chief Commercial Officer | Sell | 10,318 | $51.94 | $536K | 58,408 | +5.47% | +0.77% |
| May 28, 2026 | Levitan Lauren Cooks | — | Sell | 7,714 | $56.31 | $434K | 11,550 | -2.82% | +5.47% |
| Apr 27, 2026 | AMIN TARANG | Chief Executive Officer | Sell | 41,520 | $63.66 | $2.6M | 112,690 | -3.05% | -3.97% |
| Apr 27, 2026 | Milsten Scott | — | Sell | 23,797 | $63.66 | $1.5M | 114,940 | -3.05% | -3.97% |
| Apr 27, 2026 | MARCHISOTTO KORY | See Remarks | Sell | 23,796 | $63.66 | $1.5M | 152,417 | -3.05% | -3.97% |
| Apr 27, 2026 | FIELDS MANDY J | See Remarks | Sell | 23,656 | $63.66 | $1.5M | 77,437 | -3.05% | -3.97% |
| Apr 27, 2026 | Franks Joshua Allen | SVP, Operations | Sell | 23,535 | $63.66 | $1.5M | 118,071 | -3.05% | -3.97% |
| Apr 27, 2026 | Hartnett Jennifer Catherine | Chief Commercial Officer | Sell | 20,829 | $63.66 | $1.3M | 68,726 | -3.05% | -3.97% |
| Jun 9, 2025 | AMIN TARANG | Chief Executive Officer | Sell | 7,000 | $51.53 | $361K | 128,593 | +0.77% | +3.08% |
| Jun 4, 2025 | AMIN TARANG | Chief Executive Officer | Sell | 15,829 | $51.94 | $822K | 135,593 | +5.47% | +0.77% |
8-K · 5.02
!!! Very High
e.l.f. Beauty, Inc. -- 8-K 5.02: Executive Change
e.l.f. Beauty appointed Matthew Farrell as a Class I director, expanding its board composition and potentially signaling strategic changes in company leadership or direction.
Feb 13
8-K
e.l.f. Beauty, Inc. -- 8-K Filing
e.l.f. Beauty gained 130 basis points of market share in Q3 2025, indicating strong competitive positioning and potential revenue acceleration in the beauty market.
Feb 4
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 2,369,572 | $180M | Added | Dec 2025 |
| 2 | Vanguard Portfolio Management Llc | 2,591,001 | $157M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 2,534,402 | $154M | New | Mar 2026 |
| 4 | Jpmorgan Chase & Co | 2,236,734 | $133M | Added | Mar 2026 |
| 5 | Ensign Peak Advisors, Inc | 1,898,555 | $115M | Added | Mar 2026 |
| 6 | Clearbridge Investments, Llc | 1,734,774 | $105M | Added | Mar 2026 |
| 7 | Aqr Capital Management Llc | 1,495,715 | $90M | Added | Mar 2026 |
| 8 | Champlain Investment Partners, Llc | 1,292,895 | $78M | Added | Mar 2026 |
| 9 | Capital World Investors | 1,203,717 | $73M | Added | Mar 2026 |
| 10 | Ubs Group Ag | 841,157 | $51M | Reduced | Mar 2026 |
| 11 | Primecap Management Co/ca/ | 701,710 | $43M | Added | Mar 2026 |
| 12 | Capital Research Global Investors | 610,816 | $37M | Reduced | Mar 2026 |
| 13 | Prime Capital Management Co Ltd | 604,535 | $37M | — | Mar 2026 |
| 14 | Voya Investment Management Llc | 455,807 | $35M | Reduced | Dec 2025 |
| 15 | Northern Trust Corp | 512,766 | $31M | Added | Mar 2026 |
| 16 | Swedbank Ab | 480,801 | $29M | Reduced | Mar 2026 |
| 17 | Bank Of America Corp /de/ | 418,431 | $25M | Added | Mar 2026 |
| 18 | Bnp Paribas Financial Markets | 415,653 | $25M | Reduced | Mar 2026 |
| 19 | Bank Of New York Mellon Corp | 360,950 | $22M | Reduced | Mar 2026 |
| 20 | Aberdeen Group Plc | 358,134 | $22M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.75B
Enterprise Value
$3.85B
P/E (TTM)
33.44x
Forward P/E
17.65x
PEG Ratio
-2.16x
P/B
4.74x
P/S
2.85x
P/FCF
32.48x
EV/EBITDA
18.68x
Shares Out
58.3M
Financials (TTM)
Revenue
$1.31B
Net Income
$112.1M
EBITDA
$206.2M
Free Cash Flow
$115.3M
Op Cash Flow
$133.8M
EPS Basic
$1.99
EPS Diluted
$1.92
EPS Forward
$3.64
Gross Margin
71.2%
Op Margin
12.0%
Net Margin
8.5%
Balance Sheet
Total Assets
$1.25B
Total Liab.
$487.3M
Total Equity
$760.9M
Cash
$148.7M
LT Debt
$256.7M
Book Value/Sh
$13.54
Debt/Equity
0.41x
Current Ratio
3.05
Quick Ratio
2.00
Returns & Growth
ROE
4.3%
ROA
2.2%
ROIC
11.3%
Rev Growth YoY
+28.3%
EPS Growth YoY
-14.6%
Price Returns
2W
+1.0%
1M
-12.5%
3M
-39.2%
6M
-26.5%
12M
-50.2%
Technicals
52W High
$146.67
52W Low
$49.57
50d MA
$59.81
200d MA
$86.45
RSI (14)
63.50
ATR (14)
$3.82
Beta
2.39
Avg Volume
4.4M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$104.17
High
$121.00
Low
$85.00
Median
$106.00
Data updated apr 25, 2026 6:52am
· Source: financialmodelingprep.com